Report cover image

Brain Tumor Therapeutics: Global Markets to 2030

Publisher BCC Research
Published Oct 06, 2025
Length 120 Pages
SKU # WA20476935

Description

Report Scope

This report provides detailed information on brain tumor therapeutics. It analyzes the market trends for brain tumor therapeutics with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030 (forecast period 2025–2030) and regional markets for brain tumor therapeutics. This report highlights brain tumor therapeutics’ current and future market potential and providess a detailed competitive environment analysis. The report covers regulatory scenarios, drivers, restraints and opportunities. It also covers market projections for 2030 and the market share for key companies.

This brain tumor therapeutics market is segmented by therapy type into chemotherapy, targeted therapy and immunotherapy. The patient age segment is segmented into adults and pediatrics. The end user segment is segmented into hospitals and home care settings.

The market has been segmented into the following major regions: North America, Europe, Asia-Pacific, the Middle East and Africa and South America. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, 2024 is used as the base year, with forecasts for 2025 and a forecast value for 2030.

The report aims to:
  • Analyze types of brain tumors and related therapeutics.
  • Analyze global market size and segmentation.
  • Understand market constraints and drivers.
  • Provide detailed market forecasts for 2030.
  • Assess market shares, competitiveness and industry structure.
  • Identify potential long-term impacts on the brain tumor therapeutics market.
Report Includes
  • An overview of the current and future global market potential for brain tumor therapeutics
  • Analyses of the global market trends, with historical market revenue data from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
  • Estimates of the market size and revenue growth prospects, along with a corresponding market share analysis by therapy type, patient age group, end user and region
  • Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impacts of macroeconomic variables
  • Impact analysis of U.S. tariff laws, as well as use cases of AI adoption on the market
  • Insights derived from Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • A relevant patent analysis, featuring key granted and published patents
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
  • Profiles of the leading companies


Comapanies Mentioned

Amgen Inc.
Amneal Pharmaceuticals Llc.
Baxter
Bayer Ag
F. Hoffmann-la Roche Ltd.
Merck & Co. Inc.
Novartis Ag
Pfizer Inc.
Servier Laboratories
Teva Pharmaceutical Industries Ltd.

Table of Contents

120 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factors Analysis
Impact of U.S. Tariffs on the Pharmaceutical Industry
Healthcare Expenditure
Impact of Global Economic Growth on the Pharma Sector
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Brain Tumor Cases
Increasing R&D Spending by Market Players
Rise in Government Funding and Pharmaceutical R&D Spending
Market Restraints
Inadequate Treatment Options for Brain Tumors
High Cost of Brain Cancer Drugs
Low Screening of Brain Tumors
Market Opportunities
Increasing Availability of Biosimilars and Generics
Research Collaborations
Chapter 4 Regulatory Landscape
Regulatory Dynamics
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Pipeline Analysis
Emerging Trends/Technologies
Artificial Intelligence
Biomarkers
Pipeline Analysis
Key Takeaways
Patent Analysis
Key Takeaways
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global Brain Tumor Therapeutics Market, by Therapy Type
Key Takeaways
Chemotherapy
Targeted Therapy
Immunotherapy
Global Brain Tumor Therapeutics Market, by Patient Age
Key Takeaways
Adults
Pediatric
Global Brain Tumor Therapeutics Market, by End User
Key Takeaways
Hospitals
Home Care
Geographic Breakdown
Global Brain Tumor Therapeutics Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Sustainability in Brain Tumor Therapeutics: ESG Perspective
Introduction to ESG
Sustainability in the Brain Tumor Therapeutics Market
ESG Perspective
Environmental Impact
Social Impact
Governance Impact
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
AMGEN INC.
AMNEAL PHARMACEUTICALS LLC.
BAXTER
BAYER AG
F. HOFFMANN-LA ROCHE LTD.
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SERVIER LABORATORIES
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Emerging Players/Market Disruptors

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us